• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素药代动力学在危重病中的重要性。

The importance of antibiotic pharmacokinetics in critical illness.

作者信息

Fry D E

机构信息

Department of Surgery, University of New Mexico Health Sciences Center, Albuquerque 87131, USA.

出版信息

Am J Surg. 1996 Dec;172(6A):20S-25S. doi: 10.1016/s0002-9610(96)00346-7.

DOI:10.1016/s0002-9610(96)00346-7
PMID:9003686
Abstract

Antibiotics are the most commonly used drugs in the surgical patient. Pharmacokinetics is the study of processes that result in the delivery of drugs to effector sites. Drug absorption, distribution, biotransformation, and excretion are the critical elements of drug delivery to effector sites. The biologic elimination half-life (t1/2) and the volume of distribution (Vd) are terms used to describe the active processes of pharmacokinetics; t1/2 and Vd are determined for antibiotics by employing healthy volunteers or minimally ill patients. From these data, dosing schedules for each antibiotic are determined. This article reviews the literature on the impact of critical illness and sepsis on antibiotic pharmacokinetics. The data identify that t1/2 may be reduced in the hyperdynamic states of stress and sepsis and that the Vd is expanded. These changes mean that currently accepted dosing regimens of antibiotics in critically ill patients are inadequate. Subtherapeutic antibiotic concentrations in these patients may account for treatment failures and may be of significance in the emergence of bacterial resistance.

摘要

抗生素是外科患者最常用的药物。药代动力学是研究导致药物输送到效应部位的过程。药物吸收、分布、生物转化和排泄是药物输送到效应部位的关键要素。生物消除半衰期(t1/2)和分布容积(Vd)是用于描述药代动力学活性过程的术语;抗生素的t1/2和Vd是通过使用健康志愿者或病情较轻的患者来确定的。根据这些数据,确定每种抗生素的给药方案。本文综述了关于危重病和脓毒症对抗生素药代动力学影响的文献。数据表明,在应激和脓毒症的高动力状态下,t1/2可能会缩短,Vd会扩大。这些变化意味着目前危重病患者中抗生素的公认给药方案并不充分。这些患者中抗生素浓度低于治疗水平可能是治疗失败的原因,并且可能在细菌耐药性的出现中具有重要意义。

相似文献

1
The importance of antibiotic pharmacokinetics in critical illness.抗生素药代动力学在危重病中的重要性。
Am J Surg. 1996 Dec;172(6A):20S-25S. doi: 10.1016/s0002-9610(96)00346-7.
2
The relevance of drug volume of distribution in antibiotic dosing.药物分布容积与抗生素剂量的相关性。
Curr Pharm Biotechnol. 2011 Dec;12(12):1996-2001. doi: 10.2174/138920111798808365.
3
[Adequate anti-infective treatment : Importance of individual dosing and application].[充分的抗感染治疗:个体化给药与应用的重要性]
Anaesthesist. 2018 Jun;67(6):461-476. doi: 10.1007/s00101-018-0443-4.
4
Pharmacokinetic issues for antibiotics in the critically ill patient.危重症患者使用抗生素的药代动力学问题。
Crit Care Med. 2009 Mar;37(3):840-51; quiz 859. doi: 10.1097/CCM.0b013e3181961bff.
5
Antibiotic dosing in critically ill patients with acute kidney injury.危重症急性肾损伤患者的抗生素给药。
Nat Rev Nephrol. 2011 Apr;7(4):226-35. doi: 10.1038/nrneph.2011.12. Epub 2011 Feb 22.
6
Pharmacokinetics of antibiotics in critically ill patients.
Intensive Care Med. 1990;16 Suppl 3:S235-8. doi: 10.1007/BF01709707.
7
SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients.肾脏替代治疗中抗生素的采样(SMARRT):一项针对危重症患者的观察性药代动力学研究。
BMC Infect Dis. 2016 Mar 1;16:103. doi: 10.1186/s12879-016-1421-6.
8
Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.危重症患者时间依赖性β-内酰胺类抗生素有效给药方案的协变量决定因素。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Sep;162(3):219-226. doi: 10.5507/bp.2018.011. Epub 2018 Mar 27.
9
Factors affecting gentamicin pharmacokinetics in septic patients.影响脓毒症患者庆大霉素药代动力学的因素。
Acta Anaesthesiol Scand. 1999 Aug;43(7):726-30. doi: 10.1034/j.1399-6576.1999.430707.x.
10
Changes in vancomycin pharmacokinetics in critically ill infants.危重症婴儿万古霉素药代动力学的变化
Anaesth Intensive Care. 1995 Dec;23(6):678-82. doi: 10.1177/0310057X9502300603.

引用本文的文献

1
Differential Paradigms in Animal Models of Sepsis.脓毒症动物模型中的差异范式
Curr Infect Dis Rep. 2016 Sep;18(9):26. doi: 10.1007/s11908-016-0535-8.
2
Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment.亚胺培南在烧伤患者中的药代动力学特征及药代动力学/药效学目标达成情况。
J Antibiot (Tokyo). 2015 Mar;68(3):143-7. doi: 10.1038/ja.2014.121. Epub 2014 Sep 17.
3
Therapeutic interventions in sepsis: current and anticipated pharmacological agents.脓毒症的治疗干预:当前及预期的药物制剂
Br J Pharmacol. 2014 Nov;171(22):5011-31. doi: 10.1111/bph.12829. Epub 2014 Sep 5.
4
Cefepime dosing in the morbidly obese patient population.在病态肥胖患者人群中使用头孢吡肟进行剂量调整。
Obes Surg. 2012 Mar;22(3):465-71. doi: 10.1007/s11695-011-0586-8.
5
Antibiotic dosing in critically ill patients with acute kidney injury.危重症急性肾损伤患者的抗生素给药。
Nat Rev Nephrol. 2011 Apr;7(4):226-35. doi: 10.1038/nrneph.2011.12. Epub 2011 Feb 22.
6
Population pharmacokinetics of arbekacin in burn patients.阿贝卡星在烧伤患者中的群体药代动力学。
Eur J Clin Pharmacol. 2008 Jun;64(6):599-603. doi: 10.1007/s00228-008-0470-1.
7
Clinical scoring system for the prediction of target site penetration of antimicrobials in patients with sepsis.脓毒症患者抗菌药物靶位穿透预测的临床评分系统
Clin Pharmacokinet. 2007;46(1):75-83. doi: 10.2165/00003088-200746010-00004.
8
Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.重症监护中的抗菌药物给药:脓毒症的药代动力学、疾病程度及药效学
Clin Pharmacokinet. 2006;45(8):755-73. doi: 10.2165/00003088-200645080-00001.
9
Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.重症患者的抗菌治疗:对导致药物处置改变和药代动力学变异性的病理生理状况的综述。
Clin Pharmacokinet. 2005;44(10):1009-34. doi: 10.2165/00003088-200544100-00002.